Exelixis
EXEL
#1370
Rank
$15.98 B
Marketcap
$64.53
Share price
-1.19%
Change (1 day)
61.37%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company